Sirolimus and temsirolimus for epithelioid angiomyolipoma.
Wolff
Nicholas
N
Departments of Internal Medicine, Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Kabbani
Wareef
W
Bradley
Thomas
T
Raj
Ganesh
G
Watumull
Lori
L
Brugarolas
James
J
D000368:Aged; D018207:Angiomyolipoma / Q000188:drug therapy* / Q000473:pathology / Q000601:surgery; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D004621:Embolization, Therapeutic; D015622:Epithelioid Cells / Q000187:drug effects* / Q000473:pathology; D017707:Erythrocyte Transfusion; D006498:Hepatectomy; D006801:Humans; D007680:Kidney Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000601:surgery; D008113:Liver Neoplasms / Q000188:drug therapy* / Q000556:secondary; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000556:secondary; D008279:Magnetic Resonance Imaging; D008297:Male; D009392:Nephrectomy; D020123:Sirolimus / Q000031:analogs & derivatives* / Q000627:therapeutic use; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome; D055815:Young Adult
D000970:Antineoplastic Agents; C401859:temsirolimus; D020123:Sirolimus